Hospice remains essential to serious illness care, supported by strong beneficiary satisfaction and a growing national preference to age at home. Yet the landscape is shifting as regulators increase scrutiny, workforce shortages strain delivery, and payers link reimbursement to measurable outcomes, equity, and demonstrated value.
This perspective explains how hospice is evolving from a standalone benefit to a central part of integrated palliative, primary, and home-based care. It examines pressures related to late referrals, access disparities, and rising labor costs, and it describes how leading providers are moving toward physician-led, data-driven models that coordinate across the continuum and make clinical impact clear.
For organizations preparing for value-based contracting, expanding care at home, or strengthening serious illness strategy, this paper defines the expectations and opportunities that will shape high-performing hospice programs in the years ahead.
Please complete the form to receive this white paper. Upon submission, the white paper will be sent to your inbox.
